fluorouracil injection usp solution
pfizer canada ulc - fluorouracil - solution - 50mg - fluorouracil 50mg - antineoplastic agents
fluorouracil hikma 50 mg/ml solution for injection/infusion
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - fluorouracil - solution for injection/infusion - fluorouracil 50 mg/ml - antineoplastic agents
fluorouracil 50 mg/ml, solution for injection or infusion
pharma regulatory services limited office no.3, edgewater complex, st. julians, stj 3151,, malta - solution for injection/infusion - fluorouracil 50 mg/ml - antineoplastic agents
fluorouracil inj 50mg/ml liquid
david bull laboratories (pty) ltd. - fluorouracil - liquid - 50mg - fluorouracil 50mg - antineoplastic agents
fluorouracil 50mg/ml solution for injection or infusion
accord healthcare limited - fluorouracil 50 mg/ml - solution for infusion or injection
fluorouracil 25 mg/ml solution for inj/inf
hospira uk limited - fluorouracil sodium - solution for inj/inf - 25 mg/ml - pyrimidine analogues
fluorouracil (roche)
roche products (nz) ltd - fluorouracil 25 mg/ml - solution for injection - 250 mg/10ml - active: fluorouracil 25 mg/ml
fluorouracil injection solution
sandoz canada incorporated - fluorouracil - solution - 50mg - fluorouracil 50mg - antineoplastic agents
fluorouracil cream
spear dermatology products inc - fluorouracil (unii: u3p01618rt) (fluorouracil - unii:u3p01618rt) - fluorouracil 5 mg in 1 g - fluououracil cream 0.5% is indicated for the topical treatment of multiple actinic or solar keratoses of the face and anterior scalp. fluorouracil may cause fetal harm when administered to a pregnant woman. fluorouracil is contraindicated in women who are or may become pregnant. if this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. no adequate and well-controlled studies have been conducted in pregnant women with either topical or parenteral forms of fluorouracil. one birth defect (ventricular septal defect) and cases of miscarriage have been reported when fluorouracil was applied to mucous membrane areas. multiple birth defects have been reported in the fetus of a patient treated with intravenous fluorouracil. animal reproduction studies have not been conducted with fluorouracil cream 0.5%. fluorouracil, the active ingredient, has been shown to be teratogenic in mice, rats, and hamsters when adm
fluorouracil ebewe fluorouracil 2500 mg/50 ml solution for injection vial
sandoz pty ltd - fluorouracil, quantity: 2500 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide - alone or in combination, for the palliative treatment of malignant tumours, particularly of the breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas. fluorouracil should only be used when other proven measures have failed or are considered impractical.